DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
-2.02%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$171M
AUM Growth
+$171M
(-14%)
Cap. Flow
-$22M
Cap. Flow
% of AUM
-12.92%
Top 10 Holdings %
Top 10 Hldgs %
55.42%
Holding
80
New
10
Increased
14
Reduced
20
Closed
19
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$2.36M |
| 2 |
PayPal
PYPL
|
$1.04M |
| 3 |
TSMC
TSM
|
$938K |
| 4 |
iShares Biotechnology ETF
IBB
|
$912K |
| 5 |
SPDR Gold Trust
GLD
|
$903K |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$7.37M |
| 2 |
Amgen
AMGN
|
$2.87M |
| 3 |
Verizon
VZ
|
$2.6M |
| 4 |
Bristol-Myers Squibb
BMY
|
$2.03M |
| 5 |
Incyte
INCY
|
$1.95M |
Sector Composition
| 1 | Healthcare | 46.43% |
| 2 | Technology | 15.51% |
| 3 | Communication Services | 10.18% |
| 4 | Financials | 6.57% |
| 5 | Consumer Discretionary | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
1
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $14.6M | 6.39% | 238,500 -120,500 | -34% | -$7.37M |
|
2
AbbVie
ABBV
$372B
| $14.4M | 6.3% | 88,750 -10,568 | -11% | -$1.71M |
|
3
Micron Technology
MU
$133B
| $13M | 5.71% | 167,500 -10,000 | -6% | -$779K |
|
4
Alphabet (Google) Class C
GOOG
$2.58T
| $12.2M | 5.32% | 4,350 | – | – |
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $10.3M | 4.5% | 14,700 -2,500 | -15% | -$1.75M |
|
6
argenx
ARGX
$43.6B
| $7.88M | 3.45% | 25,000 | – | – |
|
7
Xencor
XNCR
$580M
| $6.86M | 3% | 257,000 +15,237 | +6% | +$407K |
|
8
Bank of America
BAC
$376B
| $6M | 2.63% | 145,500 | – | – |
|
|
9
SPDR Gold Trust
GLD
$107B
| $5.42M | 2.37% | 30,000 +5,000 | +20% | +$903K |
|
10
VanEck Gold Miners ETF
GDX
$19B
| $3.93M | 1.72% | 102,500 -12,500 | -11% | -$479K |
|
11
Citigroup
C
$178B
| $3.74M | 1.64% | 70,000 +2,000 | +3% | +$107K |
|
12
iShares Gold Trust
IAU
$50.6B
| $3.68M | 1.61% | 100,000 | – | – |
|
|
13
Incyte
INCY
$16.5B
| $3.61M | 1.58% | 45,500 -24,500 | -35% | -$1.95M |
|
14
Turning Point Brands
TPB
$1.79B
| $3.53M | 1.54% | 103,676 -8,250 | -7% | -$281K |
|
15
General Motors
GM
$55.8B
| $3.5M | 1.53% | 80,000 -5,000 | -6% | -$219K |
|
16
Advanced Micro Devices
AMD
$264B
| $3.28M | 1.44% | 30,000 | – | – |
|
17
Oracle
ORCL
$635B
| $3.23M | 1.41% | 39,000 -3,500 | -8% | -$290K |
|
18
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.1M | 1.36% | 19,000 +1,000 | +6% | +$163K |
|
19
Eli Lilly
LLY
$657B
| $2.96M | 1.3% | 10,350 -900 | -8% | -$258K |
|
20
Prothena Corp
PRTA
$441M
| $2.78M | 1.22% | 76,000 +16,000 | +27% | +$585K |
|
21
VanEck Junior Gold Miners ETF
GDXJ
$6.6B
| $2.58M | 1.13% | 55,000 | – | – |
|
|
AOD
22
abrdn Total Dynamic Dividend Fund
AOD
$963M
| $2.47M | 1.08% | 257,000 -2,000 | -0.8% | -$19.2K |
|
23
Pfizer
PFE
$141B
| $2.41M | 1.05% | 46,500 -18,500 | -28% | -$958K |
|
|
24
Meta Platforms (Facebook)
META
$1.86T
| $2.36M | 1.03% | +10,600 | New | +$2.36M |
|
|
IMPL
25
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $2.34M | 1.02% | 367,058 +111,031 | +43% | +$707K |
|